China's industrial profits surge in September, led by high-tech and equipment manufacturing, despite ongoing economic headwinds.
California Governor Gavin Newsom is seriously considering a 2028 presidential run, but will wait until after the 2026 midterms to make a final decision.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
China's industrial profits surge in September, led by high-tech and equipment manufacturing, despite ongoing economic headwinds.
California Governor Gavin Newsom is seriously considering a 2028 presidential run, but will wait until after the 2026 midterms to make a final decision.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.